{"id":55237,"date":"2023-03-28T17:46:03","date_gmt":"2023-03-28T06:46:03","guid":{"rendered":"https:\/\/hudsonorgau.wpengine.com\/?post_type=hdsn_news_post&#038;p=55237"},"modified":"2024-07-08T11:50:21","modified_gmt":"2024-07-08T01:50:21","slug":"t-cells-open-the-door-to-potential-immune-therapies","status":"publish","type":"hdsn_news_post","link":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/","title":{"rendered":"T cells open the door to potential immune therapies"},"content":{"rendered":"\n<p class=\"has-medium-font-size\">Keeping T cells active, but not too active, could be the key to new potential immune therapies, according to the latest research.<\/p>\n\n\n\n<p>While T cells play a critical role in the immune system by protecting our body against infection and cancer, regulation of T cell activity is necessary to prevent excessive <a href=\"https:\/\/hudson.org.au\/disease\/inflammation\/\">inflammation<\/a> and damage to healthy tissue.<\/p>\n\n\n\n<p>A team of researchers including Hudson Institute\u2019s <a href=\"https:\/\/hudson.org.au\/researcher-profile\/kate-lawlor\/\">Associate Professor Kate Lawlor<\/a> is investigating how the T cells\u2019 life and death is controlled and what molecular mechanisms are at play in the regulation of the T cells\u2019 activity.<\/p>\n\n\n\n<p>In a study published in the journal&nbsp;<em><a href=\"https:\/\/doi.org\/10.1038\/s41419-023-05619-0\" target=\"_blank\" rel=\"noreferrer noopener\">Cell Death and Disease<\/a><u>,<\/u><\/em>&nbsp;they worked with mucosal associated invariant T (MAIT) cells \u2013 a type of T cells that play a crucial role in protecting our bodies against bacterial infections.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" class=\"wp-block-heading\" id=\"potential-immune-therapies-to-control-inflammation\"><strong>Potential immune therapies to control inflammation<\/strong><\/h2>\n\n\n\n<p>The researchers found that MAIT cells have a unique survival and death mechanism compared to other types of T cells.<\/p>\n\n\n\n<p>They discovered that a protein, called RIPK3 (Receptor-Interacting Protein Kinase 3), plays a crucial role in regulating MAIT cell numbers, but the same effect was not seen for other T cell populations.<\/p>\n\n\n\n<p>University of Melbourne\u2019s Dr Timothy Patton, a Research Officer at the Doherty Institute and a lead author of the study, explained.<\/p>\n\n\n\n<p>\u201cThe RIPK3 protein controls both inflammation and cell death activity. It is a master &#8216;decision maker&#8217; controlling if a cell will die, and how much inflammation the cell will drive in both its life and death.\u201d<\/p>\n\n\n\n<p>\u201cIn MAIT cells, but not other T cells, RIPK3 plays more of a \u2018pro-death\u2019 role restricting the accumulation of MAIT cells normally.\u201d<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" class=\"wp-block-heading\" id=\"new-therapeutic-solutions\"><strong>New therapeutic solutions<\/strong><\/h2>\n\n\n\n<p>Understanding more about how MAIT cells work opens the door to new therapeutic solutions to help fight infectious diseases.<\/p>\n\n\n\n<p>\u201cThese findings suggest RIPK3 is a good target to develop therapies that can either increase or decrease the activity of MAIT cells,\u201d said University of Melbourne\u2019s&nbsp;<a href=\"https:\/\/www.doherty.edu.au\/people\/associate-professor-alexandra-corbett\" target=\"_blank\" rel=\"noreferrer noopener\">Associate Professor Alexandra Corbett,<\/a> Laboratory Head at the Doherty Institute and a senior author of the paper.<\/p>\n\n\n\n<p>\u201cThis could be useful for treating conditions where MAIT cell activity needs to be reduced, such as autoimmune diseases, or where it needs to be increased, such as bacterial infections.\u201d<\/p>\n\n\n\n<p>This research was carried out by a collaborative team of researchers at the Doherty Institute, Hudson Institute for Medical Research and the Walter and Eliza Hall Institute.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Keeping T cells active, but not too active, could be the key to new potential immune therapies, according to the latest research.&hellip;&nbsp;&nbsp;<a class=\"read-more\" href=\"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/\">Read more<\/a><\/p>\n","protected":false},"featured_media":55200,"menu_order":0,"template":"","issue":[],"tag":[],"story-type":[85],"treatment-type":[94],"class_list":["post-55237","hdsn_news_post","type-hdsn_news_post","status-publish","has-post-thumbnail","hentry","story-type-discovery","treatment-type-immunotherapies"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>T cells open the door to potential immune therapies - Hudson Institute of Medical Research<\/title>\n<meta name=\"description\" content=\"Researchers are working on regulation of T cell activity to prevent excessive inflammation and damage to healthy tissue.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"T cells open the door to potential immune therapies\" \/>\n<meta property=\"og:description\" content=\"Researchers are working on regulation of T cell activity to prevent excessive inflammation and damage to healthy tissue.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Hudson Institute of Medical Research\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-08T01:50:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/03\/Dr-Kate-Lawlor-Doherty-News-story.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/t-cells-open-the-door-to-potential-immune-therapies\\\/\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/t-cells-open-the-door-to-potential-immune-therapies\\\/\",\"name\":\"T cells open the door to potential immune therapies - Hudson Institute of Medical Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/t-cells-open-the-door-to-potential-immune-therapies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/t-cells-open-the-door-to-potential-immune-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Dr-Kate-Lawlor-Doherty-News-story.jpg\",\"datePublished\":\"2023-03-28T06:46:03+00:00\",\"dateModified\":\"2024-07-08T01:50:21+00:00\",\"description\":\"Researchers are working on regulation of T cell activity to prevent excessive inflammation and damage to healthy tissue.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/t-cells-open-the-door-to-potential-immune-therapies\\\/#breadcrumb\"},\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hudson.org.au\\\/news\\\/t-cells-open-the-door-to-potential-immune-therapies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/t-cells-open-the-door-to-potential-immune-therapies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Dr-Kate-Lawlor-Doherty-News-story.jpg\",\"contentUrl\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Dr-Kate-Lawlor-Doherty-News-story.jpg\",\"width\":600,\"height\":600,\"caption\":\"Dr Kate Lawlor\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/t-cells-open-the-door-to-potential-immune-therapies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hudson.org.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"T cells open the door to potential immune therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#website\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/\",\"name\":\"Hudson Institute of Medical Research\",\"description\":\"Transforming lives through scientific discovery.\",\"publisher\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hudson.org.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-AU\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#organization\",\"name\":\"Hudson Institute of Medical Research\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/hudson-logo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/hudson-logo-1.jpg\",\"width\":1200,\"height\":316,\"caption\":\"Hudson Institute of Medical Research\"},\"image\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"T cells open the door to potential immune therapies - Hudson Institute of Medical Research","description":"Researchers are working on regulation of T cell activity to prevent excessive inflammation and damage to healthy tissue.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/","og_locale":"en_US","og_type":"article","og_title":"T cells open the door to potential immune therapies","og_description":"Researchers are working on regulation of T cell activity to prevent excessive inflammation and damage to healthy tissue.","og_url":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/","og_site_name":"Hudson Institute of Medical Research","article_modified_time":"2024-07-08T01:50:21+00:00","og_image":[{"width":600,"height":600,"url":"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/03\/Dr-Kate-Lawlor-Doherty-News-story.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/","url":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/","name":"T cells open the door to potential immune therapies - Hudson Institute of Medical Research","isPartOf":{"@id":"https:\/\/hudson.org.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/#primaryimage"},"image":{"@id":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/03\/Dr-Kate-Lawlor-Doherty-News-story.jpg","datePublished":"2023-03-28T06:46:03+00:00","dateModified":"2024-07-08T01:50:21+00:00","description":"Researchers are working on regulation of T cell activity to prevent excessive inflammation and damage to healthy tissue.","breadcrumb":{"@id":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/#breadcrumb"},"inLanguage":"en-AU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/#primaryimage","url":"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/03\/Dr-Kate-Lawlor-Doherty-News-story.jpg","contentUrl":"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/03\/Dr-Kate-Lawlor-Doherty-News-story.jpg","width":600,"height":600,"caption":"Dr Kate Lawlor"},{"@type":"BreadcrumbList","@id":"https:\/\/hudson.org.au\/news\/t-cells-open-the-door-to-potential-immune-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hudson.org.au\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/hudson.org.au\/news\/"},{"@type":"ListItem","position":3,"name":"T cells open the door to potential immune therapies"}]},{"@type":"WebSite","@id":"https:\/\/hudson.org.au\/#website","url":"https:\/\/hudson.org.au\/","name":"Hudson Institute of Medical Research","description":"Transforming lives through scientific discovery.","publisher":{"@id":"https:\/\/hudson.org.au\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hudson.org.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-AU"},{"@type":"Organization","@id":"https:\/\/hudson.org.au\/#organization","name":"Hudson Institute of Medical Research","url":"https:\/\/hudson.org.au\/","logo":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hudson.org.au\/#\/schema\/logo\/image\/","url":"https:\/\/hudson.org.au\/wp-content\/uploads\/2017\/05\/hudson-logo-1.jpg","contentUrl":"https:\/\/hudson.org.au\/wp-content\/uploads\/2017\/05\/hudson-logo-1.jpg","width":1200,"height":316,"caption":"Hudson Institute of Medical Research"},"image":{"@id":"https:\/\/hudson.org.au\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/hdsn_news_post\/55237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/hdsn_news_post"}],"about":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/types\/hdsn_news_post"}],"version-history":[{"count":0,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/hdsn_news_post\/55237\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/media\/55200"}],"wp:attachment":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/media?parent=55237"}],"wp:term":[{"taxonomy":"issue","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/issue?post=55237"},{"taxonomy":"tag","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/tag?post=55237"},{"taxonomy":"story-type","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/story-type?post=55237"},{"taxonomy":"treatment-type","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/treatment-type?post=55237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}